← Back to headlines
F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
5 Mar, 10:01 — 5 Mar, 10:01
ℹOnly 1 source covers this story
Related Stories
Bohol lawmakers push for health, social protection measures
just now
Kura Oncology anticipates $7B AML opportunity as KOMZIFTI launches and combination strategies advance
5m ago
Ako obezita vplýva na mozog? Kľúčové je rozloženie telesného tuku
22m ago
50 Medical Schools Back Kennedy Plan on Nutrition After Pressure
37m ago